Compare Versions


PDF |Add To My Favorites |Track Bill | print page

SCR-36 Cystic Fibrosis Awareness Month.(2019-2020)



Current Version: 07/15/19 - Chaptered         Compare Versions information image


SCR36:v97#DOCUMENT

Senate Concurrent Resolution No. 36
CHAPTER 114

Relative to Cystic Fibrosis Awareness Month.

[ Filed with Secretary of State  July 15, 2019. ]

LEGISLATIVE COUNSEL'S DIGEST


SCR 36, Pan. Cystic Fibrosis Awareness Month.
This measure would proclaim the month of May 2019 as Cystic Fibrosis Awareness Month.
Fiscal Committee: NO  

WHEREAS, Cystic fibrosis, a chronic and progressive systemic disease, is the most common fatal genetic disease in the United States, and one for which there is no known cure; and
WHEREAS, Approximately 30,000 children and adults in the United States have cystic fibrosis and more than 1,000 new cases are diagnosed each year, predominantly through newborn screening; and
WHEREAS, One of every 3,500 babies born in the United States is born with cystic fibrosis; and
WHEREAS, Due to progress in understanding the disease and new therapeutic advances, the average life expectancy of individuals recently diagnosed with cystic fibrosis is in the early 40s; and
WHEREAS, Despite advances in disease understanding and new therapies, the median age of death for those with cystic fibrosis is 30 years of age; and
WHEREAS, The federal Centers for Disease Control and Prevention estimates that more than 12 million Americans are unknowing, symptomless carriers of the cystic fibrosis gene and have high odds of passing the gene to their children; and
WHEREAS, Prompt, aggressive treatment of the symptoms of cystic fibrosis can extend the lives of people who have the disease; and
WHEREAS, Recent advances in cystic fibrosis research have produced promising leads in gene, protein, and drug therapies beneficial to people who have the disease; and
WHEREAS, Cystic fibrosis research continues for potential therapies, and a nationwide network of care centers exists to improve the length and quality of life for individuals with cystic fibrosis, yet lives continue to be lost to this disease; and
WHEREAS, Cystic Fibrosis Research, Incorporated (CFRI) was formed in 1975 with a mission to fund research, provide education and personal support, and spread awareness of cystic fibrosis; and
WHEREAS, CFRI provides funding for innovative cystic fibrosis research at medical and academic centers nationwide to expand understanding of the disease process and to seek new therapies and ultimately a cure for this challenging multisystemic disease; and
WHEREAS, CFRI seeks to improve the quality of life for people with cystic fibrosis in California and the nation, as well as their family members, by providing psychosocial support programs; and
WHEREAS, Education of the public about cystic fibrosis, including the symptoms of the disease, increases knowledge and understanding of cystic fibrosis and promotes early diagnosis. CFRI serves as a vital link to the cystic fibrosis community in providing diverse educational resources; and
WHEREAS, Support for those impacted by cystic fibrosis, a rare disease, begins with the raising of public awareness. CFRI works within the cystic fibrosis community on both the state and national level to advocate for continued research, access to quality care, and the development of new therapies to extend and enhance lives; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature hereby proclaims the month of May 2019 as Cystic Fibrosis Awareness Month; and be it further
Resolved, That the Legislature honors the goals and ideals of Cystic Fibrosis Awareness Month, so as to promote public awareness and understanding of cystic fibrosis; and be it further
Resolved, That the Legislature encourages early diagnosis and access to quality care for people with cystic fibrosis to improve the quality of their lives, advocates for increased support for people who have cystic fibrosis and their families, and supports research to find a cure for cystic fibrosis; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.